Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 97.56M | $ 0 | $ 97.56M |
3/31/2025 | $ 86.17M | $ 0 | $ 86.17M |
12/31/2024 | $ 101.64M | $ 0 | $ 101.64M |
9/30/2024 | $ 111.26M | $ 0 | $ 111.26M |
6/30/2024 | $ 93.01M | $ 0 | $ 93.01M |
3/31/2024 | $ 128.96M | $ 0 | $ 128.96M |
12/31/2023 | $ 165.32M | $ 0 | $ 165.32M |
9/30/2023 | $ 219.7M | $ 0 | $ 219.7M |
6/30/2023 | $ 325.07M | $ 0 | $ 325.07M |
3/31/2023 | $ 440.57M | $ 51.55M | $ 389.01M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for SANGAMO THERAPEUTICS INC is calculated as follows: Assets [ $ 963.71M ] - Intangibles [ $ 96.55M ]
(=) Tangible Assets [ $ 867.16M ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 996.29M |
median | $ 389.26M |
std | $ 1.28B |